GB1370905A - Local anaesthetic composition - Google Patents

Local anaesthetic composition

Info

Publication number
GB1370905A
GB1370905A GB5865971A GB5865971A GB1370905A GB 1370905 A GB1370905 A GB 1370905A GB 5865971 A GB5865971 A GB 5865971A GB 5865971 A GB5865971 A GB 5865971A GB 1370905 A GB1370905 A GB 1370905A
Authority
GB
United Kingdom
Prior art keywords
local anaesthetic
anaesthetic composition
composition
local
anaesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5865971A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra USA Inc
Original Assignee
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc
Publication of GB1370905A publication Critical patent/GB1370905A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GB5865971A 1971-01-26 1971-12-17 Local anaesthetic composition Expired GB1370905A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10294271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
GB1370905A true GB1370905A (en) 1974-10-16

Family

ID=22292522

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5865971A Expired GB1370905A (en) 1971-01-26 1971-12-17 Local anaesthetic composition

Country Status (1)

Country Link
GB (1) GB1370905A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024903A1 (en) * 1994-03-17 1995-09-21 Nanning Maple Leaf Pharmaceutical Co., Ltd. The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024903A1 (en) * 1994-03-17 1995-09-21 Nanning Maple Leaf Pharmaceutical Co., Ltd. The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
US5846975A (en) * 1994-03-17 1998-12-08 Nanning Maple Leaf Pharmaceutical Co., Ltd. Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
EG10723A (en) Substituted para-menthanes
ZA727741B (en) Thermofomable compositions
HK57478A (en) Photopolymerisable composition
GB1372932A (en) Anti-caries compositions
PH10909A (en) Esterocyclic compounds and compositions thereof
ZA721353B (en) Polyamide-diazo resin composition
ZA724552B (en) Antiseborrhoeic compositions
ZA721446B (en) Substituted 3-benzylpyridines
CY958A (en) Plaster composition
GB1393014A (en) Polyurethane-tar compositions
ZA721359B (en) Substituted thiadiazolidine-diones
IE35937B1 (en) Local anaesthetic composition
IL39336A0 (en) Substituted 2-anilinobenzoxazoles
JPS5494024A (en) Photosensitive composition
ZA722089B (en) Substituted chlorocarbonylureas
GB1391562A (en) Resinous composition
GB1370905A (en) Local anaesthetic composition
GB1367202A (en) Reflex-reflecting compositions
ZA72714B (en) Substituted phenylthiocarbamates
ZA717795B (en) Anesthetic
CY755A (en) Therapeutic composition
YU282572A (en) Kuciste i poklopac kucista
ZA72669B (en) Substituted 1-phenyl-6-azacytosines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee